Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia

Leukemia

Volumn 24, Issue 6, 2010, Pages 1236-1239

  Nakasone, H ^a   Kanda, Y ^a   Takasaki, H ^b   Nakaseko, C ^c   Sakura, T ^d   Fujisawa, S ^e   Yokota, A ^f   Yano, S ^g   Usuki, K ^h   Maruta, A ^b   Abe, D ^c   Hoshino, T ^d   Takahashi, S ⁱ   Kanamori, H ^b   Okamoto, S ^j  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^e YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^f CHIBA AOBA MUNICIPAL HOSPITAL   (Japan)

^g JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h Kanto Teishin Hospital   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

^j KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DASATINIB; IMATINIB; NILOTINIB; TACROLIMUS; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER PATIENT; CANCER PREVENTION; CANCER RELAPSE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE SEVERITY; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LETTER; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; ALLOTRANSPLANTATION; DRUG EFFECT; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; MIDDLE AGED; PHILADELPHIA 1 CHROMOSOME; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HUMANS; INCIDENCE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PIPERAZINES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PYRIMIDINES; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954597881     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.83     Document Type: Letter

References (11)

1. Banovic T, MacDonald KP, Morris ES, Rowe V, Kuns R, Don A et al. TGF-beta in allogeneic stem cell transplantation: friend or foe? Blood 2005; 106: 2206-2214. (Pubitemid 41291742)
2. Svegliati S, Olivieri A, Campelli N, Luchetti M, Poloni A, Trappolini S et al. Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood 2007; 110: 237-241. (Pubitemid 47026840)
3. Alho HS, Maasilta PK, Vainikka T, Salminen US. Platelet-derived growth factor, transforming growth factor-beta, and connective tissue growth factor in a porcine bronchial model of obliterative bronchiolitis. Exp Lung Res 2007; 33: 303-320. (Pubitemid 47256047)
4. Magro L, Mohty M, Catteau B, Coiteux V, Chevallier P, Terriou L et al. Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease. Blood 2009; 114: 719-722.
5. Olivieri A, Locatelli F, Zecca M, Sanna A, Cimminiello M, Raimondi R et al. Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood 2009; 114: 709-718.
6. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956. (Pubitemid 41754712)
7. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217. (Pubitemid 10036817)
8. Olavarria E, Siddique S, Griffiths MJ, Avery S, Byrne JL, Piper KP et al. Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reducedintensity allografts for chronic myeloid leukemia. Blood 2007; 110: 4614-4617. (Pubitemid 351377831)
9. Skopouli FN, Li L, Boumba D, Stefanaki S, Hanel K, Moutsopoulos HM et al. Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjogren's syndrome. Clin Exp Rheumatol 1998; 16: 63-65. (Pubitemid 28133484)
10. Chinen H, Matsuoka K, Sato T, Kamada N, Okamoto S, Hisamatsu T et al. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells. Gastroenterology 2007; 133: 559-573. (Pubitemid 47187343)
11. Seggewiss R, Lore K, Greiner E, Magnusson MK, Price DA, Douek DC et al. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner. Blood 2005; 105: 2473-2479. (Pubitemid 40387048)